Determining the best waiting time for esophagogastroduodenoscopy after lidocaine spray
The Optimal Timing of the Initiation of Esophagogastroduodenoscopy After Oral Lidocaine Spray
This study is testing whether waiting 1 minute or 3 minutes after using lidocaine spray makes patients more comfortable during an esophagogastroduodenoscopy (EGD).
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 20 Years to 90 Years |
| Sex | All |
| Sponsor | National Cheng-Kung University Hospital Academic / other |
| Locations | 1 site (Tainan, Other (Non U.s.)) |
| Trial ID | NCT06497296 on ClinicalTrials.gov |
What this trial studies
This study investigates the optimal waiting time between the application of lidocaine spray and the initiation of esophagogastroduodenoscopy (EGD) to enhance patient comfort and compliance. Participants will be divided into two groups, receiving either a 1-minute or a 3-minute waiting period after the lidocaine application before the EGD procedure begins. The study will monitor vital signs such as heart rate and blood pressure during the procedure and assess the quality of the EGD through patient questionnaires. The goal is to standardize the waiting time to improve the overall quality and safety of the EGD examination.
Who should consider this trial
Good fit: Ideal candidates are patients aged 20 years and older scheduled for EGD due to conditions like dyspepsia, peptic ulcer disease, GERD, or diarrhea.
Not a fit: Patients with gastrointestinal bleeding or those requiring emergency procedures will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient comfort and reduced complications during EGD procedures.
How similar studies have performed: While there may be studies on sedation and anesthesia in EGD, this specific investigation into the timing of lidocaine application is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Eligible participants included patients aged ≥ 20 years who scheduled EGD from OPD for dyspepsia, peptic ulcer disease, GERD, subepithelial lesion evaluation, and diarrhea Exclusion Criteria: * GI bleeding * endoscopic submucosal dissection due to prolonged scheduled procedure time * patients from emergency department or ward
Where this trial is running
Tainan, Other (Non U.s.)
- Hsueh-Chien Chiang — Tainan, Other (Non U.s.), Taiwan (Recruiting)
Study contacts
- Study coordinator: Hsueh-Chien Chiang, M.D.
- Email: scion456scion@gmail.com
- Phone: 062353535
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.